{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Design Therapeutics, Inc.
Is Design Therapeutics, Inc. technically bullish or bearish?
As of June 20, 2025, Design Therapeutics, Inc. is in a mildly bearish trend, indicated by daily moving averages and Bollinger Bands, despite some mildly bullish signals from MACD and KST, leading to a cautious outlook.
What does Design Therapeutics, Inc. do?
Design Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $18 million and a market cap of $208.91 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -24.66%.
How big is Design Therapeutics, Inc.?
As of Jun 18, Design Therapeutics, Inc. has a market capitalization of 208.91 million and reported net sales of 0.00 million with a net profit of -56.19 million over the latest four quarters. Shareholder's funds are 242.10 million, and total assets amount to 252.09 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
